A study of childhood cancer survivors' engagement with long-term follow-up care: 'To attend or not to attend, that is the question'.

Autor: Knighting K; Faculty of Health and Social Care, Edge Hill University, Ormskirk, Lancashire, L39 4QP, UK. Electronic address: knightk@edgehill.ac.uk., Kirton JA; Faculty of Health and Social Care, Edge Hill University, Ormskirk, Lancashire, L39 4QP, UK. Electronic address: Jennifer.kirton@edgehill.ac.uk., Thorp N; The Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge Road, Bebington Wirral, CH63 4JY, UK., Hayden J; Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, L12 2AP, UK. Electronic address: j.hayden@nhs.net., Appleton L; The Clatterbridge Cancer Centre NHS Foundation Trust, Clatterbridge Road, Bebington Wirral, CH63 4JY, UK. Electronic address: Lynda.appleton@nhs.net., Bray L; Faculty of Health and Social Care, Edge Hill University, Ormskirk, Lancashire, L39 4QP, UK. Electronic address: brayl@edgehill.ac.uk.
Jazyk: angličtina
Zdroj: European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2020 Apr; Vol. 45, pp. 101728. Date of Electronic Publication: 2020 Feb 10.
DOI: 10.1016/j.ejon.2020.101728
Abstrakt: Purpose: In the UK, there are over 40,000 childhood cancer survivors (CCS); this figure grows approximately 1300 annually. Two-thirds are at risk of developing serious disabling or life-threatening conditions due to adverse late effects of the cancer or treatment received in childhood. Life-long, follow-up care for the surveillance and management of late effects is recommended. This study explored CCS' views and experiences of long-term follow-up (LTFU) care within a cancer centre.
Methods: Paper questionnaires (n = 113) and qualitative interviews (n = 13).
Results: The majority (n = 83, 80%) of CCS reported being satisfied with their LTFU care and felt that it was important to attend long-term survivorship follow-up (n = 97, 86%). However, some were not well informed about their cancer treatment history, purpose for attending the clinic or the potential for late effects. Barriers associated with LTFU included; provision of information, lack of interpersonal relationships, practical and logistic challenges.
Conclusions: Barriers identified can be addressed through strategies including provision of verbal and written information and care plans to increase CCS' knowledge of their cancer history, risk of late effects and the purpose of LTFU care, both at transition and throughout their survivorship journey; patient-centred services that enhance patient choice and flexibility of access to multiple specialities; and use of risk stratified pathways to encourage supported self-management based on cancer type, co-morbidity, and level of professional involvement required. Improving regular provision of information at critical time-points, and exploring a flexible, patient-centred delivery of LFTU care based on risk, could increase attendance and self-management in CCS.
Competing Interests: Declaration of competing interest The authors declare there are no conflicts of interest for this study.
(Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: